JOIN OUR TEAM
With the fast-evolving biopharma drug discovery and development, and the many processes involved in it, numerous big and small businesses are joining the industry value chain.
Softgels and liquid-fill capsules offer formulations greater flexibility and stability, while also catering to the need for higher drug bioavailability.
Contract manufacturing is an integral part of the pharmaceutical industry’s value chain and an increasingly powerful customer base for excipient suppliers. This interactive directory aims at mapping the pharmaceutical contract manufacturers in all the key global markets to enable excipient suppliers to identify and expand customer reach.
Commencing with this article, each month we will shine our spotlight on a confirmed or potential M&A candidate, sharing our point of view – and expertise – on the opportunities that we see.
Breaking barriers, challenging tradition, and exceeding expectations – Kline Consultant Liya Zeng talked about all that, and much more, as a panelist at the ICBS Asia Business Club’s discussion on “Women in Business” last week.
This month, Lonza is set to start the sale process of its specialty ingredients business (LSI) unit.
Brexit stands for British exit from the European Union. In order to calm the rising Euroscepticism of his own party and of vocal rival parties, such as the UK Independence Party (UKIP), Prime Minister Cameron announced in January 2013 his intention to give U.K. voters the opportunity to decide in a referendum on whether the United Kingdom should be IN or OUT of the European Community. On June 23, 2016, the result was that the electorate voted to leave the EU by a narrow margin of 51.89% to 48.11%. In fact, the majority in England and Wales were in favor of leaving, while the majority in Scotland and Northern Ireland voted to remain. Cameron had taken a risky gamble on the referendum and had underestimated the strength of Brexit feeling in certain parts of the United Kingdom. He paid for this miscalculation with his own political career.
Innovation is the lifeblood of the OTC industry. From a business perspective, it drives growth, and from a public health perspective, it better satisfies consumers’ health needs. Because innovation is so important, Kline and IRI have collaborated to examine recent OTC launches and identified their success factors including: A point of difference, big or small, real or imagined, to better address patient needs
Expert awareness-generating, heavy advertising and promotion investment
Brand equity plays
The nine brands included in this assessment and shown on the timeline graphic in Table 1, have the following characteristics and were chosen for inclusion jointly by Kline and IRI:
Launched between 2010 to 2014
A mix of Rx-to-OTC switches, new and line extensions of monograph items, and supplements
Part of IRI’s New Products Pacesetters tracking and annual review
Significant media support
Experienced double-digit growth the year after launch
Still growing in Year 2
There are significant opportunities for OTC marketers in the area of brain health. This is an area of serious concern for many individuals who either have the disease or wish to avoid succumbing to it. Current prescription drugs offer treatment for individuals with advanced levels of dementia and Alzheimer’s disease, with mixed results. However, many consumers, seeing first-hand results of brain disease in elderly parents and relatives, are eager to maintaintheir own brain health and prevent or delay the onset of dementia or Alzheimer’s disease.
Growing consumer interest in natural OTCs is mirroring widespread consumer interest in seeking more natural and less synthetic products across many categories, from food and beverages to personal care products to OTCs. Natural OTCs are drug-free and may contain natural, plant, or herbal ingredients, or be homeopathic, and are used to support, prevent, maintain, or treat minor ailments such as colds, insomnia, aches and pains, or skin problems. Retailers merchandise natural alternatives near OTC medication sections or even within the same planogram. Retailers are increasingly dedicating prime areas of stores to natural OTCs, such as high visibility end-cap displays as the example below from a Target store shows. Online sales of natural OTCs are also growing fast along with sales through natural and specialty stores focused on natural products, such as Whole Foods, Sprout, and Trader Joe’s.
